Shanghai HeartCare Medical Technology Corporation Limited Stock

Equities

6609

CNE100004MN5

Medical Equipment, Supplies & Distribution

Delayed Hong Kong S.E. 02:58:59 2024-04-26 am EDT 5-day change 1st Jan Change
17.86 HKD +4.69% Intraday chart for Shanghai HeartCare Medical Technology Corporation Limited +4.94% -39.97%

Financials

Sales 2024 * 342M 47.25M 370M Sales 2025 * 462M 63.75M 499M Capitalization 602M 83.12M 651M
Net income 2024 * 1M 138K 1.08M Net income 2025 * 37M 5.11M 39.98M EV / Sales 2024 * 0.38 x
Net cash position 2024 * 473M 65.31M 511M Net cash position 2025 * 364M 50.3M 394M EV / Sales 2025 * 0.51 x
P/E ratio 2024 *
789 x
P/E ratio 2025 *
16.4 x
Employees 368
Yield 2024 *
-
Yield 2025 *
-
Free-Float 34.14%
More Fundamentals * Assessed data
Dynamic Chart
Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Shanghai HeartCare Offloads Stake in Medical Device Developer Shenji Medical MT
Shanghai Heartcare Medical Technology Corporation Limited Appoints Xue Zongyu as the Chairperson of the Supervisory Committee CI
Shanghai Heartcare Medical Technology Corporation Limited Announces Board Changes CI
Shanghai HeartCare Medical Technology Corporation Limited(SEHK:6609) dropped from S&P Global BMI Index CI
HeartCare Medical Technology's Loss Narrows in H1 MT
Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Shanghai HeartCare Medical Technology Corporation Limited Announces Nomination Committee Changes CI
Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Shanghai Heartcare Medical Technology Corporation Limited Appoints Chen Shaoxiong as A Non-Executive Director CI
Shanghai Heartcare Medical Technology Corporation Limited Announces Resignation of Chen Gang as Non-Executive Director CI
Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2022 CI
536,714 Unlisted Foreign Shares of Shanghai HeartCare Medical Technology Corporation Limited are subject to a Lock-Up Agreement Ending on 19-AUG-2022. CI
6,731,890 Domestic Shares of Shanghai HeartCare Medical Technology Corporation Limited are subject to a Lock-Up Agreement Ending on 19-AUG-2022. CI
24,963,954 H Shares of Shanghai HeartCare Medical Technology Corporation Limited are subject to a Lock-Up Agreement Ending on 19-AUG-2022. CI
More news
1 day+4.69%
1 week+4.94%
Current month-7.94%
1 month-8.03%
3 months-15.75%
6 months-32.86%
Current year-39.97%
More quotes
1 week
15.98
Extreme 15.98
17.96
1 month
15.64
Extreme 15.64
20.30
Current year
15.64
Extreme 15.64
27.50
1 year
15.64
Extreme 15.64
43.00
3 years
15.64
Extreme 15.64
147.50
5 years
15.64
Extreme 15.64
147.50
10 years
15.64
Extreme 15.64
147.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 46 16-06-15
Chairman 39 17-10-31
Director of Finance/CFO 36 20-11-22
Members of the board TitleAgeSince
Director/Board Member 58 20-11-22
Founder 42 16-06-15
Director/Board Member 37 21-01-10
More insiders
Date Price Change Volume
24-04-26 17.86 +4.69% 100 700
24-04-25 17.06 +2.90% 88,100
24-04-24 16.58 +0.24% 116,500
24-04-23 16.54 +0.12% 103,750
24-04-22 16.52 -2.94% 75,350

Delayed Quote Hong Kong S.E., April 26, 2024 at 02:58 am EDT

More quotes
Shanghai HeartCare Medical Technology Corp Ltd is a China-based company engaged in the research and development of innovative neuro-interventional medical device. The Company's product portfolio includes both neuro-interventional and cardiac medical devices, and its main products are CaptorTM thrombectomy device (Captor) and left atrial appendage occluder. The Company's product portfolio extends from the treatment and prevention of ischemic stroke, including acute ischemic stroke and intracranial stenosis to the treatment of hemorrhagic stroke. The Company's other products include the balloon guiding catheter, the ExtraFlex distal access catheter and SupSelek microcatheter. The Company distributes its products within the domestic market.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
15.79 CNY
Average target price
27.12 CNY
Spread / Average Target
+71.75%
Consensus

Quarterly revenue - Rate of surprise